Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3751_Библиотеки_им_академика_М_И_Перельмана
.pdf
C.ChoosingtheCorrectGraft
Asmentioned,CTAshouldbeutilizedtoassessthediameteroftheaortabeforeplanningendovascular
repair,inorder to choosethe correctsizeandlengthofthegraft.Larger nativethoracicaortasrequire
largerdiameterstent-grafts.Nonaneurysmalthoracicaorticpathologies(e.g.,bluntaorticinjures)require
smaller stent-grafts. Commercial devices are available in diameters from 21 to 45 mm, which can
accommodatevarious typesofaorticpathologies. Fifteentotwenty percentoversizingisrecommended
for thoracic aortic endograft; however, excessive oversizing may lead to dreaded retrograde aortic
dissection.56 It is important to note that the aortic diameter decreases dramatically in patients with
traumaticaorticinjurywithhemodynamicinstabilityduetohypotension.Thisdecreaseinaorticdiameter
couldleadtoinaccurateaorticmeasurementsandundersizingoftheendograft.
57
D.DebranchingProcedures
Theneedfordebranchingproceduresforimportantbranchvesselsshouldbedeterminedpreoperatively
bystudyingtheproximalanddistallandingzones.
55
1.ArchVesselBypass
a. Archvessel bypass needs to be considered when the proximal landing zones involve any of the
aorticarchvessels.Notinfrequently,oneormoreofthearchbranchesmayneedtobecoveredforan
adequatesealtobeobtained.Forthesubclavianartery,ameta-analysisof1161patientshasshown
thatleftsubclavianarteryrevascularization didnot significantlyreducethe riskofstrokes,spinal
cord injury, or mortality.58 In another review, symptoms of upper extremity ischemia requiring
subsequentrevascularizationoccurredinonly4%ofpatients.
59
b. Preemptiverevascularizationshouldbeperformedinpatientswithadominantleftvertebralartery,
hypoplasticrightvertebralartery,orincompletecircleofWillis,asinterruptionincirculationwould
lead to an increased risk of stroke and paraplegia.
60,61
Planned revascularization can also be
consideredinpatients withpatentleftinferiormammaryartery-coronarybypassorfunctioningleft
upperextremity dialysis arteriovenous access.62Carotid-subclavian bypass or subclavian-carotid
transposition procedures can restore the left subclavian flow. The optimal procedure should be
based on duplexultrasonography ofthevertebral andcarotidarteries. However,both procedures
havenotproducedabenefitintermsofneurologicaloutcomesandmortality.
63
c. If the proximal landing zone is anticipated to cover the left common carotid artery or the
brachiocephalictrunk,open,antegradebypassfromtheascendingaortaorcarotidtranspositioncan
beperformed.Alternatively,extra-anatomicbypass(e.g.,carotid-carotidbypass)canbeperformed
toavoidsternotomy.
64,65
d. Timingofdebranching procedurecanbe in thesamesetting,orfewdaysbefore theendovascular
procedure.
2.VisceralBypass
a. Celiacarterycoveragemay frequentlybe indicatedinordertogainadequatedistalsealingofthe
grafttoavoidtypeIbendoleak.Celiaccoveragecanposeariskformesentericischemia.However,
successful cases of covering the celiac artery have been reported inpatients with a documented
patentpancreaticoduodenal system, witha low incidence ofmesenteric ischemia.
66,67
Ina recent
literaturereview,coveringtheceliacartery,withoutdeliberateaccompanyingceiliacembolization,
https://t.me/med1917

resultedinonlythreetypeIIendoleaksin72patients,whichrequiredtreatmentbycoilembolization.
68
b. Landingdistaltothesuperiormesentericarteryortherenalvesselsrequiresspecialmeasures,either
by open surgical bypass, use of special fenestrated grafts,69 use of branched grafts,70 or
revascularizationusing snorkelorchimneystents
71,72
(Fig.6.8).Debranchingprocedures can also
providebloodflowviaalternativevesselstoallowcoverageofthevisceralsegmentoftheaorta.
73
Debranchingprocedurescanbeperformedinthesamesettingorseveraldaysbeforerepair.
FIGURE6.8 TEVARwithdualbranchdeviceforresidualaorticdissectionaftergraftreplacementofascending
aortafortypeAaorticdissection.TEVAR,thoracicendovascularaorticrepair.
Reprintedwithpermissionfrom
KurataniT.Bestsurgicalopt ionforarchextensionofty p eBdissection:theendovascularapproach.AnnCardiothoracSurg.2014;3:292-299.
E.OtherApproaches
Forjuxtarenalaorticaneurysms,fenestratedendovascularaneurysmrepair(FEVAR)continuestoevolve
to avoid the need for debranching procedures.
74,75
The Zenith Fenestrated Endovascular Graft (Cook
Medical) is the primarily studied device. The use of accessory stents, such as the chimney/snorkel
technique,
76,77
or in situ fenestration of the graft using a needle or laser has also been described,
especiallyinassociationwithemergencysurgerytoavoiddebranchingprocedures.78Branchedgraftsare
beinginvestigatedforthoracicorthoracoabdominalaneurysms,79buttherateofrepair-relatedmortality
maybehigherthanconventionalgrafts.
VIII.PreoperativePreparation
A.Antibiotics
Practice guidelines recommend antibiotic prophylaxis with Cefazolin within 30 minutes of the skin
incision80(vancomycinorclindamycinmaybeusedincaseofpenicillinallergy).Antibioticsshouldbe
discontinuedwithin24hoursgiventhelackofprovenbenefitbeyondthattime.
B.RenalInjury
https://t.me/med1917

1.TentofifteenpercentofpatientsfollowingTEVARcansufferacutekidneyinjury(AKI),mostofwhom
aretypeBDescADpatients,typicallytreatedonlyafterorganmalperfusionhasoccurred.81Riskfactors
forrenalinjuryarepoorpreoperativekidneyfunction,aneurysmsoftherenalarteries,andneedforblood
transfusion.
82
2. Contrast-induced nephropathy from use of contrast during CTA can be avoided with appropriate
hydrationbeforeendovascularrepair,andbyadequatepreoperativeplanningoflandingzonestoachieve
atightsealwithouttheuseoflargeamountsofcontrast.
C.CerebrospinalFluidDrainage
1. Spinal cord perfusion pressure equals the mean arterial pressure minus the cerebrospinal fluid
pressure. Spinaldrainageaims atdecreasing the pressureinthe subarachnoid space around thespinal
cord,therebyincreasingthespinalcordperfusionpressure,anddecreasingtheincidenceofspinalcord
ischemiaduringorafterendovascularstentingofthoracicaorta.Thisisachievedviainsertionofadrain
attheleveloftheL3-L4discinthesubarachnoidspace.
83
2. Data from the European Collaborators on Stent/Graft Techniques for Aortic Aneurysm Repair
(EUROSTAR)registryhighlightedthe importance ofcollateralcirculationforthespinalcord perfusion
duringendovascularrepair.84Aspinaldrainisindicatedwhenextensivecoverageofthethoracicaortais
required,whentherearemultipleinternaliliacarteryocclusions,orwhenthereisapriorhistoryofopen
orendovascularrepair.
85–87
In astudywith72patients,the riskofspinalcordischemia was 12.5%in
patients withprior abdominal aortic aneurysmrepair,versus 1.7% in patientswithout prior repair.
85
Another retrospective cohort study of endovascular repair of Crawford Type II thoracoabdominal
aneurysmsshowedthatstagedrepairwasassociatedwithlowerriskofspinalcordischemia,compared
withsinglestagedrepair(11.1%vs37.5%).88Apromisingspinalcoolingcatheterhasbeendeveloped,
whichdrainscerebrospinalfluid(CSF)aswellasproducinglocalizedspinalcordhypotension.Clinical
applicationofthiscatheterisexpectedsoon.
89
IX.TechniqueofPlacement
Endovascular repairofthoracic aortais performed undergeneral anesthesia,whichallows respiratory
controlandmorepreciseimaging.IntheEUROSTARregistry,technicalsuccesswasachievedin87%of
aneurysmpatientsand89%ofDescADpatients.
90
A.AccessVessels
1. Large-bore sheaths needtobe introducedthrough thefemoral artery, typicallybyfemoral cutdown.
Unlike abdominal aortic repair, percutaneous access is usually difficult because of larger devices;
however,trialsusingthe“Preclosetechnique”forTEVARhavebeensuccessful.91Itislikelythatinthe
future,percutaneousaccesswillbeimplementedforthoracicaneurysmsaswell.
92
2. In 3.8%-9.4% of patients, femoral cutdown is not suitable and other access sites are required.
93
Tortuous,calcific,ornarrowiliacarteriesmaynotbesuitabletopasssuchlargedevices,soaccesscan
beobtainedthroughaniliacconduit,directexposureofthecommoniliacartery,directdeliverythrough
the abdominal aorta, or by balloon angioplasty ofthe iliac arteries before procedures. In challenging
access situations, antegrade access through the ascending aorta has been described for descending
thoracicendografts.
94
https://t.me/med1917

B.Deployment
1.Wireaccessisgainedintotheascendingaortaandexchangedforastiffwiretoallowtrackingofthe
device.Positioningthegraftistypicallyachievedunderfluoroscopy,alongwithothertechniquessuchas
transesophagealechocardiography(TTE)andintravascularultrasound.95Aftervascularaccesshasbeen
obtained, lowering blood pressure is needed only transiently at the moment of deployment. Blood
pressureislowered,pharmacologicallyorbyrapidpacing,downtothe60s,inordertopreventthegraft
frommovingdistallyowingtopressure(i.e.,wind-sockeffect).
2.Whentheproximallandingzoneinvolvesthearch,a30-60°leftanterioroblique(LAO)projectionis
usedtopreciselysplay outthearch vessels.Forthe distallandingzone neartheceliac trunk,a lateral
projection is used. Once the device is deployed in position, the stent-graft is expanded and can be
balloonedattheproximalanddistallandingzonestostabilizeinplace.
C.EvaluatingforEndoleaks
Aortographyistypicallyperformedafterdeploymenttoensurecorrectpositioningofthegraft,patencyof
branch vessels, aneurysmal sac occlusion, andto checkfor thepresence ofanendoleak,which is the
persistenceofflowintheaneurysmsacafterrepair.Removalofthesheathandrepairofthearteriotomy
isthenperformed.
D.PostoperativeImaging
It isrecommendedtoobtaina CTAwithin 1 monthoftheprocedure,at6 monthsand then annuallyto
evaluate for endograft integrity and location, for persistence of the aneurysm sac, and for late
complicationsandendoleaks
96
X.Complications
A.PerioperativeMortalityandMorbidity
1.WiththeadvancementofTEVARdevicesandtechniques,perioperativemortalityratesinsomestudies
are lower than in open repair. In a multicenter study for descending thoracic aneurysms in low-risk
patients, perioperative mortality rates were 2.1% for endovascular repair versus 11.7% in patients
undergoingopenrepair(P<0.001).97AccordingtotheNationalSurgicalQualityImprovementProgram
(NSQIP)database,theoperativeindicationsforTEVARprocedurewerenotfoundtobeapredictorof
poorpatientoutcome.However,patientspresentingwithemergencyconditions,suchasruptureoraortic
dissection,hadhigherratesof30-daymortality(22.6%vs6.2%),98aswellashigherlatemortalityrates.
99
2.IntheNSQIPdatabase,perioperativemorbidityassociatedwithTEVARwasfoundtobe9%,
30
with
thecumulativemajormorbidityscoressignificantlylower thantheopengroupat30days(1.3±3.0vs
2.9±3.6,respectively,P<.01).Nodifferenceinsurvivalbetweenmalesandfemaleswasnoted.
100–103
B.Endoleaks
1.Endoleakisatermthatdescribesthepresenceofpersistentflowofbloodintotheaneurysmsacafter
endograft placement, which poses a risk for aneurysm expansion and rupture. Endoleak is usually
recognizeduponaortographyafterdeploymentoftheendograft,oratpostprocedureCTscan.However,
https://t.me/med1917

endoleak can appear up to 5 years after repair.
104
Long-term follow-up of patients who underwent
endovascular repair for abdominal aortic aneurysms showed high rates of endoleak development,
reaching approximately30%,withanaveragefollow-upof6 years.
105
Thissuggeststhat TEVAR may
recapitulatethehighendoleakratewhenmanylatecasesbecomeavailableforanalysis.
2.Classificationofendoleaksisbasedonthesourceoftheleak
106
(Table6.4),whichhelpsdetermine
theappropriatemanagementplan.TypeIIendoleakisthemostprevalenttypeandisduetopatentaortic
branches, especially intercostal and lumbar arteries.
107
Continued aneurysm sac expansion without a
demonstrable endoleak on any imaging modality is referred to as endoleak of undefined origin, also
calledtypeVendoleakorendotension.
108
Table6.4
ClassificationofEndoleaks
TypeofEndoleak Description
TypeI
Ia
Inadequatesealattheproximalend
Ib
Inadequatesealatthedistalend
Ic
Inadequatesealatiliacoccluder
TypeII Sacfillingviaanaorticbranchvessel
IIa
Singlevessel
IIb
Twovesselsormore
TypeIII Leakthroughadefectingraftfabric
IIIa
Junctionalseparationofthemodularcomponent
IIIb
Holesinvolvingtheendograft
TypeIV Leakthroughporousgraftmaterial
TypeV Continuedaneurysmsacexpansionwithoutademonstrableendoleakonanyimagingmodality
3.TherateofendoleakswithTEVARhasbeennotedtobesomewherebetween3.9%
30
and15.6%in
anotherreview.
109
4. It is noted that complex fenestrated, branched, and chimney endografts introduce the potential for
additional modes of failure in terms of component separation and endoleaks. Treatment of endoleaks
associatedwiththesedevicesremainschallenging.
110
C.SpinalCordIschemia
1.TEVARcarriesarealriskofspinalcordischemiaandparaplegia,comparabletoratesreportedafter
opensurgicalrepair.Theratesofspinalcordinjuryandparaplegiaafteropenthoracoabdominalaortic
repairincontemporaryseriesrangefrom3% to12%,
111–118
andfrom 5%to10% in endovascularand
hybrid procedures.
90,115,119–122
In a retrospective cohort of 724 patients who were treated with either
TEVAR(n=352)oropenrepair(372),forthoracicorthoracoabdominalaneurysms,theratesofspinal
https://t.me/med1917

cordinjurieswerenotsignificantlydifferent(4.3%intheendovasculargroupvs7.5%intheopengroup).
2.Theextentofcoverageoftheaortaisthemajorriskfactorforspinalcordischemia.
111
3. Patients withprior endovascular repair also tend tohavean increased risk, as well as those with
preoperative renal insufficiency.
123
In the European Registry of Endovascular Aortic Repair
Complications (EuREC), simultaneousclosure of atleasttwo vascular territories supplying the spinal
cordwasfoundtoincreasetheriskofspinalcordinjury,alongwithlongperioperativehypotension.
124
D.Stroke
Insituationswheretheaneurysmsacextendstothearch,proximallandingzonescancomeinproximityto
thecarotid andvertebralarteries, leadingtoembolicstrokesand cerebrovascularcomplications.Prior
strokes,alongwiththepresenceofheavyatheromatousburdenintheaorticarch,arestrongriskfactors
fordevelopmentofsuchevents.
125
Posteriorcirculationstrokescanresultfromembolireachingthecircle
ofWillisfromthevertebralandsubclavianarteries(subclavianstumpsyndrome).
126
Inonestudywith1002patients,strokeoccurredin4.8%ofpatientsundergoingTEVAR,inwhom,prior
revascularization of the subclavian artery seemed to protect against posterior circulation strokes.
127
Another study has foundthe riskofstroke tobe6.25%, with higher ratesofcomplicationsinpatients
presentingwithemergentconditions.
128
E.Ischemia
1.Extremityischemia.Althoughinfrequent,coverageoftheleftsubclavianarterycanleadtoischemic
complications, in patients requiring proximal landing in the arch. Planned revascularization of the
subclavianarterybeforeTEVARshouldbeconsideredinat-riskpatients;thiscandecreasetheischemic
complications,albeitincreasingtheintraoperativemorbidity.
60
2. Visceral ischemia. Coverage of celiac trunkor the superior mesenteric arterycanlead to visceral
ischemiainpatientswiththoracoabdominalaneurysmsinvolvingthesevitalstructures.Carefulplanning
of debranching procedures or the use of other intraoperative techniques should be carried out before
TEVAR.
Renal ischemia and acute kidney injury (AKI) can also occur, with risk factors being preoperative
decreasedGFR,extentofthoracoabdominalrepair,andpostoperativetransfusion.
82
F.AccessComplications
Owingtothelargedevices,vascularcomplicationsattheaccesssitesarenotinfrequent.Calcific,small
tortuous vessels are at higher risk. When iliac rupture occurs, balloon occlusion can be used for
temporaryvascularcontroluntilthearterycanberepaired.
G.PostimplantationSyndrome
Endothelialactivationbythe endograftcanlead toa systemicinflammatoryresponse,characterizedby
fever, leukocytosis, and elevation ofinflammatory markers, with the response being more apparent in
acuteaorticpathologies.
129,130
XI.LateComplications
https://t.me/med1917

A.SurvivalandOutcomes
1.Medicaredatabaseinformationfrom2005to2010ofmorethan1100patientswhounderwentTEVAR
has revealed the median survival tobe 57.6 months.
131
The early and late incidence of death varied
significantlybyaorticdisease.Patientswithaorticrupture,acuteaorticdissection,andaortictraumahad
the highest early incidence of death, whereas late survival was highest in patients with acute aortic
dissection, aortic trauma, and isolated thoracic aortic aneurysm, particularly those not requiring
subclavianarterycoverage.
2. Combinedexperiencefrom theEUROSTAR andUnitedKingdom Thoracic Endograftregistries has
shownthe 1-yearmortality amongpatients treatedforaortic aneurysmandaortic dissectiontobe20%
and10%,respectively.Itisimportanttomentionthatmostofthesepatientshadmultiplecomorbidities
andwerenotsurgicalcandidates.
3.Questionsaboutthedurabilityandintegrityoftheseendograftsareyettobeansweredandcontinued
useofregistriesshouldprovidedatafromlong-termfollow-up.
B.MigrationoftheGraft
Caudal migration of the graft canhappen, especially with oversizing, tortuous aortas, and inabilityto
obtainappropriatetightsealsatthelandingzones.Inonestudy,therateofmigration(>10mm)was2.8%.
30
Deviceenfoldingorcollapsecanalsooccur,leadingtoocclusionmanifestations.
132
C.SecondaryIntervention
1.Secondaryinterventionisusuallyrequiredafterendoleaks,devicemigration,ororganischemia,with
multiplereportsontheincidenceoftheseimportantcomplications.Inastudywith680patientswhowere
treatedwithTEVARfrom2000to2012,reinterventionwasneededin73patients(11.7%),withamedian
intervalof210days.Endograftfailuresincludedendoleakin45,proximalaorticevents(retrogradetype
Aoraneurysmaldegeneration)in11,distalaorticevents(dissectionoraneurysmaldegeneration)in15,
endograftinfectionin3,andothersin6.
133
2.Inanotherreviewof585patients,theneedforsecondaryinterventionwas12%withamedianfollow-
upof5.6months.
134
XII.Conclusion
Endovascular repair of the descending thoracic aorta has witnessed major advancements in the
techniques, graft design, and applicability to various aortic pathologies. Careful planning before the
procedure is indispensable in order to correctly address the pathology and to avoid complications.
Technique of deployment depends on the device type and the pathology addressed. TEVAR has the
advantageofabsence of thoracotomyincisionandaortic cross-clamping.Nonetheless, TEVARcarries
real risks of morbidity and mortality. Long-term evidence about the reliability and durability ofthese
devices remains unelucidated, as registries continue to build follow-up on the patients treated. A
multidisciplinary approach is required in management of patients, to choose the best method of
management,eitherwithTEVARorwithopenrepair.Openrepairisquitesafeatexperiencecentersand
offersanearly“bulletproof”permanencevis-a-visthetreatedaorticsegment.
References
https://t.me/med1917

1.DakeMD,MillerDC,SembaCP,MitchellRS,WalkerPJ,LiddellRP.Transluminalplacementofendovascularstent-graftsforthe
treatmentofdescendingthoracicaorticaneurysms.NEnglJMed.1994;331:1729-1734.
2.FillingerMF,GreenbergRK,McKinseyJF,ChaikofEL;SocietyforVascularSurgeryAdHocCommitteeonTRS.Reportingstandards
forthoracicendovascularaorticrepair(TEVAR).JVascSurg.2010;52:1022-1033,1033.e1015.
3.BiglioliP,RobertoM,CannataA,etal.Upperandlowerspinalcordbloodsupply:thecontinuityoftheanteriorspinalarteryandthe
relevanceofthelumbararteries.JThoracCardiovascSurg.2004;127:1188-1192.
4.MakarounMS,DillavouED,KeeST,etal.Endovasculartreatmentofthoracicaorticaneurysms:resultsofthephaseIImulticentertrial
oftheGORETAGthoracicendoprosthesis.JVascSurg.2005;41:1-9.
5.GrabenwogerM,AlfonsoF,BachetJ,etal.ThoracicEndovascularAorticRepair(TEVAR)forthetreatmentofaorticdiseases:a
positionstatementfromtheEuropeanAssociationforCardio-ThoracicSurgery(EACTS)andtheEuropeanSocietyofCardiology(ESC),
incollaborationwiththeEuropeanAssociationofPercutaneousCardiovascularInterventions(EAPCI).EurJCardiothoracSurg.
2012;42:17-24.
6.CoadyMA,IkonomidisJS,CheungAT,etal.Surgicalmanagementofdescendingthoracicaorticdisease:openandendovascular
approaches:ascientificstatementfromtheAmericanHeartAssociation.Circulation.2010;121:2780-2804.
7.CoadyMA,RizzoJA,HammondGL,etal.Whatistheappropriatesizecriterionforresectionofthoracicaorticaneurysms?JThoracic
CardiovascSurg.1997;113:476-491;discussion489–491.
8.DaviesRR,GoldsteinLJ,CoadyMA,etal.Yearlyruptureordissectionratesforthoracicaorticaneurysms:simplepredictionbasedon
size.AnnThoracSurg.2002;73:17-28.
9.ElefteriadesJA.Naturalhistoryofthoracicaorticaneurysms:indicationsforsurgery,andsurgicalversusnonsurgicalrisks.AnnThorac
Surg.2002;74:S1877-S1880;discussionS1892–1878.
10.HiratzkaLF,BakrisGL,BeckmanJA,etal.2010ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVMGuidelinesforthe
DiagnosisandManagementofPatientsWithThoracicAorticDisease.AReportoftheAmericanCollegeofCardiology
Foundation/AmericanHeartAssociationTaskForceonPracticeGuidelines,AmericanAssociationforThoracicSurgery,American
CollegeofRadiology,AmericanStrokeAssociation,SocietyofCardiovascularAnesthesiologists,SocietyforCardiovascularAngiography
andInterventions,SocietyofInterventionalRadiology,SocietyofThoracicSurgeons,andSocietyforVascularMedicine.Circulation.
2010;121:e266-e369.
11.ErbelR,AboyansV,BoileauC,etal.2014ESCGuidelinesonthediagnosisandtreatmentofaorticdiseases:documentcoveringacute
andchronicaorticdiseasesofthethoracicandabdominalaortaoftheadult.TheTaskForcefortheDiagnosisandTreatmentofAortic
DiseasesoftheEuropeanSocietyofCardiology(ESC).EurHeartJ.2014;35:2873-2926.
12.PattersonB,DeBruinJL,BrownriggJR,etal.CurrentendovascularmanagementofacutetypeBaorticdissection—whomshouldwe
treatandwhen?JCardiovascSurg.2014;55:491-496.
13.FattoriR,TsaiTT,MyrmelT,etal.ComplicatedacutetypeBdissection:issurgerystillthebestoption?:areportfromtheInternational
RegistryofAcuteAorticDissection.JACCCardiovascInterv.2008;1:395-402.
14.DuebenerLF,LorenzenP,RichardtG,etal.Emergencyendovascularstent-graftingforlife-threateningacutetypeBaorticdissections.
AnnThoracSurg.2004;78:1261-1266;discussion1266–1267.
15.FattoriR,MontgomeryD,LovatoL,etal.SurvivalafterendovasculartherapyinpatientswithtypeBaorticdissection:areportfromthe
InternationalRegistryofAcuteAorticDissection(IRAD).JACCCardiovascInterv.2013;6:876-882.
16.GrabenwögerM,AlfonsoF,BachetJ,etal.ThoracicEndovascularAorticRepair(TEVAR)forthetreatmentofaorticdiseases:a
positionstatementfromtheEuropeanAssociationforCardio-ThoracicSurgery(EACTS)andtheEuropeanSocietyofCardiology(ESC),
incollaborationwiththeEuropeanAssociationofPercutaneousCardiovascularInterventions(EAPCI).EurHeartJ.2012;33:1558-1563.
17.NienaberCA,RousseauH,EggebrechtH,etal.RandomizedcomparisonofstrategiesfortypeBaorticdissection:theINvestigationof
STEntGraftsinAorticDissection(INSTEAD)trial.Circulation.2009;120:2519-2528.
18.NienaberCA,KischeS,RousseauH,etal.EndovascularrepairoftypeBaorticdissection:long-termresultsoftherandomized
investigationofstentgraftsinaorticdissectiontrial.CircCardiovascInterv.2013;6:407-416.
19.DemetriadesD,VelmahosGC,ScaleaTM,etal.Operativerepairorendovascularstentgraftinblunttraumaticthoracicaorticinjuries:
resultsofanAmericanAssociationfortheSurgeryofTraumaMulticenterStudy.JTrauma.2008;64:561-570;discussion570–561.
20.CanaudL,OzdemirBA,BeeWW,BahiaS,HoltP,ThompsonM.Thoracicendovascularaorticrepairinmanagementof
aortoesophagealfistulas.JVascSurg.2014;59:248-254.
21.KiguchiM,ChaerRA.Endovascularrepairofthoracicaorticpathology.ExpertRevMedDevices.2011;8:515-525.
22.JordanWDJr,RovinJ,MoainieS,etal.ResultsofaprospectivemulticentertrialofCTAGthoracicendograft.JVascSurg.
2015;61:589-595.
23.https://www.goremedical.com/products/ctag---specifications.Vol.2018.
24.MelissanoG,TshombaY,CiviliniE,ChiesaR.Disappointingresultswithanewcommerciallyavailablethoracicendograft.JVascSurg.
2004;39:124-130.
25.ChoJS,HaiderSE,MakarounMS.Endovasculartherapyofthoracicaneurysms:GoreTAGtrialresults.SeminVascSurg.2006;19:18-
24.
26.BrunkwallJ,KasprzakP,VerhoevenE,etal.EndovascularrepairofacuteuncomplicatedaortictypeBdissectionpromotesaortic
remodelling:1yearresultsoftheADSORBtrial.EurJVascEndovascSurg.2014;48:285-291.
https://t.me/med1917

27.27VouteMT,BastosGoncalvesF,VerhagenHJ.Commentaryon‘ADSORB:astudyontheefficacyofendovasculargraftingin
uncomplicatedacutedissectionofthedescendingaorta’.EurJVascEndovascSurg.2012;44:37.
28.FarberMA,GigliaJ,StarnesB,etal.TEVARusingtheredesignedTAGDevice(CTAG)fortraumaticaortictransection:a
nonrandomizedmulticentertrial.JVascSurg.2012;55:622.
29.MelissanoG,TshombaY,RinaldiE,ChiesaR.Initialclinicalexperiencewithanewlow-profilethoracicendograft.JVascSurg.
2015;62:336-342.
30.MatsumuraJS,CambriaRP,DakeMD,etal.Internationalcontrolledclinicaltrialofthoracicendovascularaneurysmrepairwiththe
ZenithTX2endovasculargraft:1-yearresults.JVascSurg.2008;47:247-257;discussion257.
31.LeeWA,MartinTD,HessPJJr,BeaverTM,KlodellCT.FirstUnitedStatesexperienceoftheTX2Pro-Formthoracicdelivery
system.JVascSurg.2010;52:1459-1463.
32.LombardiJV,CambriaRP,NienaberCA,etal.Prospectivemulticenterclinicaltrial(STABLE)ontheendovasculartreatmentof
complicatedtypeBaorticdissectionusingacompositedevicedesign.JVascSurg.2012;55:629-640.e622.
33.FairmanRM,TuchekJM,LeeWA,etal.PivotalresultsfortheMedtronicValiantThoracicStentGraftSystemintheVALORIItrial.J
VascSurg.2012;56:1222-1231.e1221.
34.ThompsonM,IvazS,CheshireN,etal.EarlyresultsofendovasculartreatmentofthethoracicaortausingtheValiantendograft.
CardiovascInterventRadiol.2007;30:1130-1138.
35.ConradMF,TuchekJ,FreezorR,BavariaJ,WhiteR,FairmanR.ResultsoftheVALORIItrialoftheMedtronicValiantThoracic
StentGraft.JVascSurg.2017;66:335-342.
36.RiambauV,ZipfelB,CoppiG,etal.FinaloperativeandmidtermresultsoftheEuropeanexperienceintheRELAYEndovascular
RegistryforThoracicDisease(RESTORE)study.JVascSurg.2011;53:565-573.
37.RiambauV;RESTOREcollaborators.Europeanexperiencewithrelay:anewstentgraftanddeliverysystemforthoracicandarch
lesions.JCardiovascSurg.2008;49:407-415.
38.ZipfelB,CzernyM,FunovicsM,etal.EndovasculartreatmentofpatientswithtypesAandBthoracicaorticdissectionusingRelay
thoracicstent-grafts:resultsfromtheRESTOREPatientRegistry.JEndovascTher.2011;18:131-143.
39.IngleseL,MollichelliN,MeddaM,etal.EndovascularrepairofthoracicaorticdiseasewiththeEndoFitstent-graft:shortandmidterm
resultsfromasinglecenter.JEndovascTher.2008;15:54-61.
40.QuL,RaithelD.Two-yearsingle-centerexperiencewiththoracicendovascularaorticrepairusingtheEndoFitthoracicstent-graft.J
EndovascTher.2008;15:530-538.
41.BergeronP,IngleseL,GayJ;DedicatedRegistryCollaborators.SettingupofamulticentricEuropeanregistrydealingwithtypeB
dissectionsinchronicandacutephaseswiththoracicEndoFitdevices.JCardiovascSurg.2007;48:689-695.
42.ZipfelB,BuzS,HammerschmidtR,KrabatschT,DuesterhoeftV,HetzerR.EarlyclinicalexperiencewiththeE-vitathoracicstent-
graftsystem:asinglecenterstudy.JCardiovascSurg.2008;49:417-428.
43.StefanovF,MorrisL,ElhelaliA,etal.InsightsfromcomplexaorticsurgerywithaStreamlinerdeviceforaorticarchrepair(STAR).J
ThoracCardiovascSurg.2016;152:1309-1318.e1305.
44.SultanS,HynesN,SultanM;CollaboratorsMFM.Whennottoimplantthemultilayerflowmodulator:lessonslearnedfromapplication
outsidetheindicationsforuseinpatientswiththoracoabdominalpathologies.JEndovascTher.2014;21:96-112.
45.VaislicCD,FabianiJN,ChocronS,etal.One-yearoutcomesfollowingrepairofthoracoabdominalaneurysmswiththemultilayerflow
modulator:reportfromtheSTRATOtrial.JEndovascTher.2014;21:85-95.
46.HynesN,SultanS,ElhelaliA,etal.Systematicreviewandpatient-levelmeta-analysisofthestreamlinermultilayerflowmodulatorinthe
managementofcomplexthoracoabdominalaorticpathology.JEndovascTher.2016;23:501-512.
47.VaislicCD,FabianiJN,ChocronS,etal.Three-yearoutcomeswiththemultilayerflowmodulatorforrepairofthoracoabdominal
aneurysms:afollow-upreportfromtheSTRATOtrial.JEndovascTher.2016;23:762-772.
48.KaladjiA,SpearR,HertaultA,SobocinskiJ,MaurelB,HaulonS.Centerlineisnotasaccurateasoutercurvaturelengthtoestimate
thoracicendograftlength.EurJVascEndovascSurg.2013;46:82-86.
49.Muller-EschnerM,RengierF,PartoviS,etal.Accuracyandvariabilityofsemiautomaticcenterlineanalysisversusmanualaortic
measurementtechniquesforTEVAR.EurJVascEndovascSurg.2013;45:241-247.
50.NakatamariH,UedaT,IshiokaF,etal.Discriminantanalysisofnativethoracicaorticcurvature:riskpredictionforendoleakformation
afterthoracicendovascularaorticrepair.JVascIntervRadiol.2011;22:974-979.e972.
51.GasperWJ,ReillyLM,RappJH,etal.Assessingtheanatomicapplicabilityofthemultibranchedendovascularrepairof
thoracoabdominalaorticaneurysmtechnique.JVascSurg.2013;57:1553-1558;discussion1558.
52.KasirajanK,DakeMD,LumsdenA,BavariaJ,MakarounMS.Incidenceandoutcomesafterinfoldingorcollapseofthoracicstent
grafts.JVascSurg.2012;55:652-658;discussion658.
53.JonkerFH,SchlosserFJ,GeirssonA,SumpioBE,MollFL,MuhsBE.Endograftcollapseafterthoracicendovascularaorticrepair.J
EndovascTher.2010;17:725-734.
54.SmithTA,GatensS,AndresM,ModrallJG,ClagettGP,ArkoFR.Hybridrepairofthoracoabdominalaorticaneurysmsinvolvingthe
visceralvessels:comparativeanalysisbetweennumberofvesselsreconstructed,conduit,andgender.AnnVascSurg.2011;25:64-70.
55.GreenbergRK,LytleB.Endovascularrepairofthoracoabdominalaneurysms.Circulation.2008;117:2288-2296.
https://t.me/med1917

56.CanaudL,OzdemirBA,PattersonBO,HoltPJ,LoftusIM,ThompsonMM.Retrogradeaorticdissectionafterthoracicendovascular
aorticrepair.AnnSurg.2014;260:389-395.
57.JonkerFH,VerhagenHJ,MojibianH,DavisKA,MollFL,MuhsBE.Aorticendograftsizingintraumapatientswithhemodynamic
instability.JVascSurg.2010;52:39-44.
58.HajibandehS,HajibandehS,AntoniouSA,TorellaF,AntoniouGA.Meta-analysisofleftsubclavianarterycoveragewithandwithout
revascularizationinthoracicendovascularaorticrepair.JEndovascTher.2016;23:634-641.
59.DunningJ,MartinJE,ShennibH,ChengDC.Isitsafetocovertheleftsubclavianarterywhenplacinganendovascularstentinthe
descendingthoracicaorta?InteractCardiovascThoracSurg.2008;7:690-697.
60.RehmanSM,VechtJA,PereraR,etal.Howtomanagetheleftsubclavianarteryduringendovascularstentingofthethoracicaorta.
EurJCardiothoracSurg.2011;39:507-518.
61.WaterfordSD,ChouD,BombienR,UzunI,ShahA,KhoynezhadA.Leftsubclavianarterialcoverageandstrokeduringthoracic
aorticendografting:asystematicreview.AnnThoracSurg.2016;101:381-389.
62.DexterD,MaldonadoTS.LeftsubclavianarterycoverageduringTEVAR:isrevascularizationnecessary?JCardiovascSurg.
2012;53:135-141.
63.MadenciAL,OzakiCK,BelkinM,McPheeJT.Carotid-subclavianbypassandsubclavian-carotidtranspositioninthethoracic
endovascularaorticrepairera.JVascSurg.2013;57:1275-1282.e1272.
64.SzetoWY,BavariaJE,BowenFW,WooEY,FairmanRM,PochettinoA.Thehybridtotalarchrepair:brachiocephalicbypassand
concomitantendovascularaorticarchstentgraftplacement.JCardSurg.2007;22:97-102;discussion103–104.
65.BergeronP,MangialardiN,CostaP,etal.Greatvesselmanagementforendovascularexclusionofaorticarchaneurysmsand
dissections.EurJVascEndovascSurg.2006;32:38-45.
66.VaddineniSK,TaylorSM,PattersonMA,JordanWDJr.Outcomeafterceliacarterycoverageduringendovascularthoracicaortic
aneurysmrepair:preliminaryresults.JVascSurg.2007;45:467-471.
67.LeonLRJr,MillsJLSr,JordanW,etal.Therisksofceliacarterycoverageduringendoluminalrepairofthoracicandthoracoabdominal
aorticaneurysms.VascEndovascularSurg.2009;43:51-60.
68.JimJ,CaputoFJ,SanchezLA.Intentionalcoverageoftheceliacarteryduringthoracicendovascularaorticrepair.JVascSurg.
2013;58:270-275.
69.YuriK,YokoiY,YamaguchiA,HoriD,AdachiK,AdachiH.Usefulnessoffenestratedstentgraftsforthoracicaorticaneurysms.
EurJCardiothoracSurg.2013;44:760-767.
70.ShahverdyanR,GawendaM,BrunkwallJ.Triple-barrelgraftasanovelstrategytopreservesupra-aorticbranchesinarch-TEVAR
procedures:clinicalstudyandsystematicreview.EurJVascEndovascSurg.2013;45:28-35.
71.RiesenmanPJ,ReevesJG,KasirajanK.Endovascularmanagementofarupturedthoracoabdominalaneurysm-damagecontrolwith
superiormesentericarterysnorkelandthoracicstent-graftexclusion.AnnVascSurg.2011;25:555.e555–559.
72.PecoraroF,PfammatterT,MayerD,etal.Multipleperiscopeandchimneygraftstotreatrupturedthoracoabdominalandpararenal
aorticaneurysms.JEndovascTher.2011;18:642-649.
73.BocklerD,KotelisD,GeisbuschP,etal.Hybridproceduresforthoracoabdominalaorticaneurysmsandchronicaorticdissections—a
singlecenterexperiencein28patients.JVascSurg.2008;47:724-732.
74.GreenbergRK,SternberghWCIII,MakarounM,etal.IntermediateresultsofaUnitedStatesmulticentertrialoffenestratedendograft
repairforjuxtarenalabdominalaorticaneurysms.JVascSurg.2009;50:730–737.e731.
75.TambyrajaAL,FishwickNG,BownMJ,NasimA,McCarthyMJ,SayersRD.Fenestratedaorticendograftsforjuxtarenalaortic
aneurysm:mediumtermoutcomes.EurJVascEndovascSurg.2011;42:54-58.
76.XueY,SunL,ZhengJ,etal.Thechimneytechniqueforpreservingtheleftsubclavianarteryinthoracicendovascularaorticrepair.Eur
JCardiothoracSurg.2015;47:623-629.
77.ZhuY,GuoW,LiuX,JiaX,XiongJ,WangL.Thesingle-centreexperienceofthesupra-archchimneytechniqueinendovascular
repairoftypeBaorticdissections.EurJVascEndovascSurg.2013;45:633-638.
78.RedlingerREJr,AhanchiSS,PannetonJM.Insitulaserfenestrationduringemergentthoracicendovascularaorticrepairisaneffective
methodforleftsubclavianarteryrevascularization.JVascSurg.2013;58:1171-1177.
79.WangZG,LiC.Single-branchendograftfortreatingstanfordtypeBaorticdissectionswithentrytearsinproximitytotheleftsubclavian
artery.JEndovascTher.2005;12:588-593.
80.BratzlerDW,DellingerEP,OlsenKM,etal.Clinicalpracticeguidelinesforantimicrobialprophylaxisinsurgery.AmJHealthSyst
Pharm.2013;70:195-283.
81.PisimisisGT,KhoynezhadA,BashirK,KruseMJ,DonayreCE,WhiteRA.Incidenceandriskfactorsofrenaldysfunctionafter
thoracicendovascularaorticrepair.JThoracCardiovascSurg.2010;140:S161-S167.
82.PiffarettiG,MariscalcoG,BonardelliS,etal.Predictorsandoutcomesofacutekidneyinjuryafterthoracicaorticendograftrepair.J
VascSurg.2012;56:1527-1534.
83.CheungAT,WeissSJ,McGarveyML,etal.Interventionsforreversingdelayed-onsetpostoperativeparaplegiaafterthoracicaortic
reconstruction.AnnThoracSurg.2002;74:413-419;discussion420–411.
84.ButhJ,HarrisPL,HoboR,etal.Neurologiccomplicationsassociatedwithendovascularrepairofthoracicaorticpathology:Incidence
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана
